Fluent Corp. logo

Fluent Corp. (CNTMF)

Market Closed
5 Dec, 20:00
OTCQB OTCQB
$
0. 04
0
0%
$
31.84M Market Cap
- P/E Ratio
0% Div Yield
395,100 Volume
-0.12 Eps
$ 0.04
Previous Close
Day Range
0.04 0.05
Year Range
0.04 0.09
Want to track CNTMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CNTMF closed Friday higher at $0.04, an increase of 0% from Thursday's close, completing a monthly decrease of -14.58% or $0.01. Over the past 12 months, CNTMF stock lost -47.44%.
CNTMF is not paying dividends to its shareholders.
The last earnings report, released on Nov 28, 2025, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTCQB (USD).

CNTMF Chart

Similar

Sunniva Inc.
$ 0
0%
Western Capital Resources Inc.
$ 15.1
0%
C21 Investments Inc.
$ 0.32
-0.93%
Greystone Logistics Inc.
$ 0.58
+1.75%
International Isotopes Inc.
$ 0.07
+16.67%
Top Marijuana Stocks To Watch In A Volatile Sector 2025

Top Marijuana Stocks To Watch In A Volatile Sector 2025

Marijuana stock investors are back waiting for another rise in trading. These last few weeks have been a window of upward trading and stronger momentum. Not only did this show the possibilities of stronger trading in the future, but it also restored investors' confidence. For a long while, the cannabis sector has been on a consistent downtrend due to the politics around reform. Now that Donald Trump has voiced his concerns about federal reform for cannabis, most marijuana stocks have seen better trading.

Marijuanastocks | 3 months ago
Weekly Watchlist: Best Marijuana Penny Stocks for July 2025

Weekly Watchlist: Best Marijuana Penny Stocks for July 2025

The U.S. cannabis industry is growing rapidly. Legal sales are expected to reach $45 billion in 2025 alone. Additionally, the sector is projected to grow at a double-digit rate annually over the decade. Adult-use marijuana is now legal in nearly half of all U.S. states. Furthermore, tax revenues continue rising as more states launch legal markets. Job creation within the industry has surpassed many other sectors. As a result, investor attention has shifted toward undervalued marijuana penny stocks. These low-priced equities often carry more volatility. Therefore, using technical analysis is essential when trading them. Identifying key support and resistance zones can enhance entry and exit points. However, success also requires managing downside risk. Setting stop losses and controlling position size can help limit exposure. This week, traders are watching several names for breakouts. Industry growth, combined with policy momentum, may create short-term price action worth trading.

Marijuanastocks | 5 months ago
3 Top Marijuana Stocks For Your Summer Watchlist

3 Top Marijuana Stocks For Your Summer Watchlist

Some of the top marijuana stocks are still struggling to gain momentum in the market. Although this may be true for some companies, others are doing well and showing why legal cannabis makes a difference. To date, almost all of the USA and many global regions have legalized cannabis. In the US, companies were able to report strong 2025 quarterly earnings. These results range from increases in revenue and business development.

Marijuanastocks | 5 months ago

Fluent Corp. (CNTMF) FAQ

What is the stock price today?

The current price is $0.04.

On which exchange is it traded?

Fluent Corp. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is CNTMF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 31.84M.

Has Fluent Corp. ever had a stock split?

No, there has never been a stock split.

Fluent Corp. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Robert Beasley CEO
OTCQB Exchange
CA13809L1094 ISIN
United States Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cansortium Inc., established in 2018 and based in Tampa, Florida, operates through its subsidiaries to provide medical cannabis in the states of Florida, Pennsylvania, and Texas. The company focuses on the production and sale of medical cannabis products, catering to patients' needs under the Fluent brand name. Alongside its proprietary products, Cansortium Inc. markets various third-party medical cannabis products, expanding its offerings to cater to a broader range of preferences and requirements within the medical cannabis community.

Products and Services

Under the Fluent brand name, Cansortium Inc. offers a diverse array of medical cannabis products designed to meet different consumer preferences and medical requirements:

  • Oral Drops: Liquid cannabis extracts designed for oral consumption, offering a discreet and easy dosage method for patients.
  • Capsules: Pre-measured, convenient form of cannabis, ideal for those seeking precise dosages without inhalation.
  • Topicals: Cannabis-infused creams and balms applied directly to the skin, targeting localized relief without systemic effects.
  • Syringes: Pure cannabis oil in syringes for precise dosing, versatile for oral, topical, or inhalation use.
  • Dried Flower: Traditional form of cannabis for smoking or vaporizing, catering to users preferring a natural consumption method.
  • Pre-rolls: Ready-to-use cannabis cigarettes that remove the hassle of grinding, rolling, and sealing cannabis flowers.
  • Cartridges: Cannabis oil cartridges for vaporizers, offering a discreet and portable inhalation option.
  • Concentrates: Highly potent cannabis extracts for experienced users, available in various textures and potencies.
  • Edibles: Cannabis-infused foods providing a smokeless consumption alternative with delayed but prolonged effects.

In addition to the Fluent-branded products, Cansortium Inc. also provides a selection of third-party branded medical cannabis products, ensuring patients have access to a wide range of therapeutic options.

Contact Information

Address: 5540 West Executive Drive
Phone: 305 902 2720